Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
FS222, a CD137/PD-L1 Tetravalent Bispecific Antibody, Exhibits Low Toxicity and Antitumor Activity in Colorectal Cancer Models.
Clin Cancer Res. 2020 Aug 1;26(15):4154-4167. doi: 10.1158/1078-0432.CCR-19-2958. Epub 2020 Apr 28.
Clin Cancer Res. 2020.
PMID: 32345647
CD137/OX40 Bispecific Antibody Induces Potent Antitumor Activity that Is Dependent on Target Coengagement.
Gaspar M, Pravin J, Rodrigues L, Uhlenbroich S, Everett KL, Wollerton F, Morrow M, Tuna M, Brewis N.
Gaspar M, et al. Among authors: wollerton f.
Cancer Immunol Res. 2020 Jun;8(6):781-793. doi: 10.1158/2326-6066.CIR-19-0798. Epub 2020 Apr 9.
Cancer Immunol Res. 2020.
PMID: 32273279
Item in Clipboard
Generation of Fcabs targeting human and murine LAG-3 as building blocks for novel bispecific antibody therapeutics.
Everett KL, Kraman M, Wollerton FPG, Zimarino C, Kmiecik K, Gaspar M, Pechouckova S, Allen NL, Doody JF, Tuna M.
Everett KL, et al. Among authors: wollerton fpg.
Methods. 2019 Feb 1;154:60-69. doi: 10.1016/j.ymeth.2018.09.003. Epub 2018 Sep 9.
Methods. 2019.
PMID: 30208333
Item in Clipboard
Cite
Cite